NasdaqGS - Nasdaq Real Time Price USD
Century Therapeutics, Inc. (IPSC)
0.5200
-0.0018
(-0.34%)
At close: May 8 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-110,135
-110,135
-88,348
14,052
-89,002
Investing Cash Flow
47,482
47,482
61,132
-13,128
-298,338
Financing Cash Flow
74,563
74,563
-9,725
27,158
417,774
End Cash Position
61,213
61,213
49,303
86,244
58,162
Income Tax Paid Supplemental Data
501
501
3,107
1,097
983
Capital Expenditure
-154
-154
-13,736
-30,604
-44,970
Issuance of Capital Stock
74,563
74,563
516
27,158
381,243
Issuance of Debt
--
--
--
--
0
Repayment of Debt
0
0
-10,241
0
--
Free Cash Flow
-110,289
-110,289
-102,084
-16,552
-133,972
12/31/2021 - 6/18/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HLVX HilleVax, Inc.
1.9100
+3.24%
EPIX ESSA Pharma Inc.
1.7100
-1.16%
SPRO Spero Therapeutics, Inc.
0.5750
-0.52%
RPTX Repare Therapeutics Inc.
1.3600
0.00%
KZR Kezar Life Sciences, Inc.
4.1200
+0.98%
PMVP PMV Pharmaceuticals, Inc.
0.8838
-0.67%
ANTX AN2 Therapeutics, Inc.
1.2200
-1.61%
IKNA Ikena Oncology, Inc.
1.0800
-0.92%
TBPH Theravance Biopharma, Inc.
9.90
-0.90%
CLRB Cellectar Biosciences, Inc.
0.2515
+2.99%